Clinical Trial Update: Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of fulvestrant in premenopausal women with hormone receptor-positive breast cancer has completed. The provided update does not include study res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED